Gynecological

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
C31004A Phase 2, Randomized Study of MLN0128 (a Dual TORC1/2 Inhibitor), MLN0128+MLN1117 (a PI3Kα Inhibitor), Weekly Paclitaxel, or the Combination of Weekly Paclitaxel and MLN0128 in Women With Advanced, Recurrent, or Persistent Endometrial CancerHirte, Dr HalOpenNCT02725268
B9991010A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AND/OR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCERHirte, Dr HalOpenNCT02718417
FORWARD 1A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab soravtansine (IMGN853) Versus Investigator’s Choice of Chemotherapy in Women with Folate Receptor α−positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube CancerHirte, Dr HalOpenNCT02631876
OVC.1A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib
to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian,
fallopian tube, or primary peritoneal cancer
Eiriksson, Dr LuaOpenNCT02446600
PHL-086A Study of XL184 (Cabozantinib) in Endometrial CancerHirte, Dr HalOn holdNCT01815151
Download PDF